Last reviewed · How we verify

NCT05715307: CREATION

Chinese Endocrinologists Health Education Study

Active, enrolled NA Last updated 16 May 2025
What this trial tests

NA trial testing Intensive training for endocrinologists in T2DM management in Type 2 Diabetes in 2,017 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
9 February 2023
Primary endpoint
25 October 2024
31 October 2025

Quick facts

Lead sponsorShanghai Jiao Tong University School of Medicine
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment2,017
Start date9 February 2023
Primary completion25 October 2024
Estimated completion31 October 2025
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Shanghai Jiao Tong University School of Medicine

Who can join

Adults 40 to 65, any sex, with Type 2 Diabetes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to conduct a prospective, multicenter, cluster randomized control study, to evaluate the improvement for T2DM treatment ability in Chinese endocrinologists after 1-week intensive experiential diabetes management training in Ruijin Hospital.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Type 2 Diabetes

Currently open trials in the same condition.

Other Shanghai Jiao Tong University School of Medicine trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05715307.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing